Nonacus

“Our customers rely on us to handle their sensitive information with the utmost care,” Sam Clokie, Director of Bioinformatics and Software at Nonacus, has been instrumental in establishing ISO27001 standards at the company. Having worked in world leading genomics laboratories himself, (in the NHS no less), he knows just how important data security is to our customers. His efforts, alongside a team of others, resulted in a successful BSI audit and the delivery of a pristine, white ISO27001 certificate last week - which will no doubt be framed and on the wall at HQ - and rightly so. Learn more about our commitment to keeping your data safe. https://bit.ly/4e4hnJ5 #ISO27001 #customertrust #datasecurity

It took blood, sweat and tears but we did it! Our ISO 27001 certificate has finally arrived for our cloud-based GALEAS software and panel design tool. Whilst we were working to ISO standards already, we are delighted that the audit by BSI confirmed that our information security management system (ISMS) meets all the requirements of ISO 27001. (To be honest our CEO thought we already had this covered so he’s REALLY pleased too). Now we can sit back and relax (and so can you) knowing that your data is safe with us. Of course, we’re not really sitting back and relaxing. Gaining ISO27001 certification is just the beginning. We will be working hard behind the scenes to maintain that standard and to continuously improve our ISMS. We are also busy doing all sorts of things in pursuit of our mission - a world where early cancer diagnosis, detection and management is simple and universally available – so watch this space. In the meantime, learn more about our commitment to keeping your data safe. https://bit.ly/40iKzZM #ISO27001 #InformationSecurity #customertrust #Galeasbladder

We were delighted to welcome Rik Bryan to Nonacus HQ yesterday for a truly inspiring talk. He shared the story of how the research under taken by his team at the University of Birmingham led to the development of the GALEAS Bladder test. This test looks to address some of the key issues facing genetic testing labs, doctors and ultimately people with suspected bladder cancer. With studies now taking place across the NHS comparing the results of this non-invasive urine test to that of a cystoscopy, and feedback from consultant urologists overwhelmingly positive, we are excited to be a part of this journey with him. Find out more. https://bit.ly/4ff7p8L #galeasbladder #noninvasive #genetictesting #cancertesting

Familial Hypercholesterolemia (FH) is a serious genetic disorder that increases cholesterol levels and the risk of heart disease. Early detection and treatment can help individuals with FH live longer and reduce the burden of cardiovascular disease. With the Cell3™ Target FH panel, clinicians can now identify key genetic variants faster and more accurately. Learn more here: https://bit.ly/3MU88jB #FamilialHypercholesterolemia #GeneticTesting #Nonacus #FHpanel #FHDetection #Cell3Target #KnowFH

We are proud to announce that Nonacus has been awarded the tender by the NHS All Wales Medical Genomics Service (AWMGS) to provide familial hypercholesterolaemia (FH) testing using our NGS custom-designed panels.🧬 This partnership marks another step forward in our mission to bring ultra-sensitive products to clinical services. Early identification of FH is critical, as it can reduce the risk of heart disease for the 34 million people affected worldwide—90% of whom are undiagnosed. A huge thank you to AWMGS and the NHS for continuing to trust our technology to support this important work. We look forward to continuing our collaboration to improve patient care and health outcomes.🙌 Read more about this exciting partnership here: https://lnkd.in/eHFayQHd #KnowFH #FamilialHypercholesterolaemia #Nonacus #FHTesting

We’re here at the ISHG conference at the Royal College of Physicians of Ireland in Dublin, Ireland! Our new team member, Myah Mahal is here until 7pm today with Elizabeth Coakley from Informed Genomics to showcase our cutting-edge products from advanced comprehensive genomics profiling for detecting SNVs, INDELS and CNVs! Don’t miss the chance to connect and learn more! 💙 #ISHG2024 #Genomics #Nonacus

We're one step closer to non-invasive bladder cancer testing being the standard 🙌 It's wonderful to see #GALEASBladder working to be integrated into routine #NHS care. The potential of enabling non-invasive bladder cancer testing from the comfort of a patient’s home in the UK is only the beginning. The vision is to enable affordable access to this new standard of care globally, to reduces burden on clinicians and reassures patients that healthcare professionals put patient comfort first. #bladdercancer #patientfirst

Hello Dublin! 🇮🇪 Nonacus is proud to sponsor the 27th Meeting of Irish Society of Human Genetics at the Royal College of Physicians Ireland on Thursday 19th September 2024. Join our new Sales and Customer Service Executive, Myah Mahal at ISHG. She'll be showcasing our GALEAS products for advanced comprehensive genomics profiling and our Cell3 Target Nexome solution for detecting SNVs, INDELS and CNVs Don't miss out on this exciting opportunity to learn more about our cutting-edge genomic solutions! Discover more on our website🖥️ https://bit.ly/4dYvwZ3

At Nonacus, we are passionate about advancing women’s health through non-invasive cancer testing. Sânziana Foia’s Papcup could be a significant step forward, offering women the option to test for HPV at home. If successful, this could break down barriers to cervical screening and empower more women to take charge of their health. 💗 How much more likely would you be to get tested from the comfort of your home? 🏡 Cancer Research UK (CRUK) #CerivcalCancer #NonInvasiveHealthcare

HRD (Homologous Recombination Deficiency) testing is becoming a game-changer in personalized cancer treatment. Comment below with your experiences and insights! Let's learn from each other. 🌟 #HRDTesting #PersonalizedMedicine #Oncology